305 related articles for article (PubMed ID: 34460099)
21. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
22. Expression of p16 and HPV E4 on biopsy samples and methylation of FAM19A4 and miR124-2 on cervical cytology samples in the classification of cervical squamous intraepithelial lesions.
Leeman A; Jenkins D; Del Pino M; Ordi J; Torné A; Doorbar J; Meijer CJLM; van Kemenade FJ; Quint WGV
Cancer Med; 2020 Apr; 9(7):2454-2461. PubMed ID: 32022461
[TBL] [Abstract][Full Text] [Related]
23. Reliable identification of women with CIN3+ using hrHPV genotyping and methylation markers in a cytology-screened referral population.
Leeman A; Del Pino M; Marimon L; Torné A; Ordi J; Ter Harmsel B; Meijer CJLM; Jenkins D; Van Kemenade FJ; Quint WGV
Int J Cancer; 2019 Jan; 144(1):160-168. PubMed ID: 30098013
[TBL] [Abstract][Full Text] [Related]
24. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
25. Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women.
De Strooper LM; Hesselink AT; Berkhof J; Meijer CJ; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1933-7. PubMed ID: 24962840
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a methylation classifier for predicting pre-cancer lesion among women with abnormal results between HPV16/18 and cytology.
Gu YY; Zhou GN; Wang Q; Ding JX; Hua KQ
Clin Epigenetics; 2020 Apr; 12(1):57. PubMed ID: 32317020
[TBL] [Abstract][Full Text] [Related]
27. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
28. Clinical Evaluation of DNA Ploidy for the Triage of HPV-Positive Chinese Women During Cervical Cancer Screening.
Cang W; Li Q; Gu L; Hong Z; Hu Y; Di W; Qiu L
Cancer Prev Res (Phila); 2021 Mar; 14(3):355-362. PubMed ID: 33229338
[TBL] [Abstract][Full Text] [Related]
29. Reflex high-risk human papilloma virus DNA test is useful in the triage of women with atypical squamous cells cannot exclude high-grade squamous intraepithelial lesion.
Wu HH; Allen SL; Kirkpatrick JL; Elsheikh TM
Diagn Cytopathol; 2006 Oct; 34(10):707-10. PubMed ID: 16955480
[TBL] [Abstract][Full Text] [Related]
30. FAM19A4/miR124-2 Methylation Testing and Human Papillomavirus (HPV) 16/18 Genotyping in HPV-Positive Women Under the Age of 30 Years.
Vink FJ; Meijer CJLM; Hesselink AT; Floore AN; Lissenberg-Witte BI; Bonde JH; Pedersen H; Cuschieri K; Bhatia R; Poljak M; Oštrbenk Valenčak A; Hillemanns P; Quint WGV; Del Pino M; Kenter GG; Steenbergen RDM; Heideman DAM; Bleeker MCG
Clin Infect Dis; 2023 Feb; 76(3):e827-e834. PubMed ID: 35686306
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus (HPV) testing in the management of women with abnormal Pap smears. Experience of a colposcopy referral clinic.
Ciotti M; Sesti F; Paba P; Benedetto A; Patrizi L; Criscuolo A; Piccione E; Branca M; Syrjänen K; Favalli C
Eur J Gynaecol Oncol; 2004; 25(5):577-84. PubMed ID: 15493169
[TBL] [Abstract][Full Text] [Related]
32. PAX1 methylation analysis by MS-HRM is useful in triage of high-grade squamous intraepithelial lesions.
Wang ZM
Asian Pac J Cancer Prev; 2014; 15(2):891-4. PubMed ID: 24568514
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
[TBL] [Abstract][Full Text] [Related]
34. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.
Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB
Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628
[TBL] [Abstract][Full Text] [Related]
35. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
[TBL] [Abstract][Full Text] [Related]
36. Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
Lindroth Y; Pedersen L; Alssamaray J; Berglund T; Sundqvist A; Borgfeldt C; Forslund O
Acta Obstet Gynecol Scand; 2024 Feb; 103(2):378-386. PubMed ID: 37964497
[TBL] [Abstract][Full Text] [Related]
37. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
[TBL] [Abstract][Full Text] [Related]
39. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
Clarke MA; Luhn P; Gage JC; Bodelon C; Dunn ST; Walker J; Zuna R; Hewitt S; Killian JK; Yan L; Miller A; Schiffman M; Wentzensen N
Int J Cancer; 2017 Aug; 141(4):701-710. PubMed ID: 28500655
[TBL] [Abstract][Full Text] [Related]
40. PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study.
Cao D; Yang Z; Dong S; Li Y; Mao Z; Lu Q; Xu P; Shao M; Pan L; Han X; Yuan J; Fan Q; Chen L; Wang Y; Zhu W; Yu W; Wang Y
BMC Med; 2024 Feb; 22(1):55. PubMed ID: 38317152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]